Literature DB >> 8567034

Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation.

J Jones1, B P Morgan.   

Abstract

Human polymorphonuclear leucocytes (PMN) express proteins that protect them from damage by homologous complement. Protection may be particularly important when these cells migrate to inflammatory sites where complement activation is taking place. Resolution of inflammation involves removal of these PMN. The major mechanism of removal is likely to involve PMN apoptosis followed by recognition and engulfment by macrophages. However, little attention has been paid to the possible relevance of apoptosis to PMN susceptibility to immune effectors. Here we describe a reduction in cell surface expression of two complement regulatory proteins, CD59, an inhibitor of the membrane attack complex and CD55 (decay accelerating factor), an inhibitor of the C3/C5 convertase, on a subpopulation of PMN aged in culture. Loss of these proteins, both attached to the membrane by glycosyl phosphatidylinositol (GPI) anchors, correlated closely with the appearance of apoptotic morphology. We also observed a marked reduction in expression of the GPI-anchored molecule CD16 on apoptotic PMN. Reduced expression of membrane proteins was not confined to those anchored through GPI--several transmembrane molecules including CD11a CD11b and CD18 were also reduced on apoptotic PMN, whilst other were little changed (CD35, CD46). The precipitous fall in CD16 surface expression on PMN was not specific for apoptosis--in vitro incubation of PMN with lipopolysaccharide-inhibited apoptosis but caused a reduction in CD16 expression to 'apoptotic' levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567034      PMCID: PMC1384068     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies.

Authors:  P A Kemp; J H Spragg; J C Brown; B P Morgan; C A Gunn; P W Taylor
Journal:  J Clin Lab Immunol       Date:  1992

2.  Macrophage recognition of senescent neutrophils.

Authors:  J Savill
Journal:  Clin Sci (Lond)       Date:  1992-12       Impact factor: 6.124

3.  Activation of the complement system in rheumatoid synovitis.

Authors:  S Ruddy; K F Austen
Journal:  Fed Proc       Date:  1973-02

4.  Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators.

Authors:  A Lee; M K Whyte; C Haslett
Journal:  J Leukoc Biol       Date:  1993-10       Impact factor: 4.962

5.  The role of apoptosis (programmed cell death) in haemopoiesis and the immune system.

Authors:  P D Allen; S A Bustin; A C Newland
Journal:  Blood Rev       Date:  1993-03       Impact factor: 8.250

Review 6.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

7.  Lipopolysaccharide and granulocyte colony-stimulating factor delay neutrophil apoptosis and ingestion by guinea pig macrophages.

Authors:  C Yamamoto; S Yoshida; H Taniguchi; M H Qin; H Miyamoto; Y Mizuguchi
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis.

Authors:  J Jones; I Laffafian; A M Cooper; B D Williams; B P Morgan
Journal:  Br J Rheumatol       Date:  1994-08

9.  Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression.

Authors:  I Dransfield; A M Buckle; J S Savill; A McDowall; C Haslett; N Hogg
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

10.  Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro.

Authors:  C H Homburg; M de Haas; A E von dem Borne; A J Verhoeven; C P Reutelingsperger; D Roos
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

View more
  24 in total

1.  Specific binding of an antigen-antibody complex to apoptotic human neutrophils.

Authors:  Simon P Hart; Caroline Jackson; L Maximillian Kremmel; Mary S McNeill; Hubertus Jersmann; Karen M Alexander; James A Ross; Ian Dransfield
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 2.  Ca2+ influx shutdown during neutrophil apoptosis: importance and possible mechanism.

Authors:  Khurram Ayub; Maurice B Hallett
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

Review 3.  Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement.

Authors:  S P Hart; J R Smith; I Dransfield
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

4.  Increased Escherichia coli phagocytosis in neutrophils that have transmigrated across a cultured intestinal epithelium.

Authors:  P Hofman; M Piche; D F Far; G Le Negrate; E Selva; L Landraud; A Alliana-Schmid; P Boquet; B Rossi
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 5.  The role of complement in danger sensing and transmission.

Authors:  Jörg Köhl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes.

Authors:  Stephen E Christmas; Claudia T de la Mata Espinosa; Deborah Halliday; Cheryl A Buxton; Joanne A Cummerson; Peter M Johnson
Journal:  Immunology       Date:  2006-09-26       Impact factor: 7.397

7.  Levels of soluble Fc gammaRIII correlate with disease severity in sepsis.

Authors:  A C Muller Kobold; J G Zijlstra; H R Koene; M de Haas; C G Kallenberg; J W Tervaert
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

8.  Apoptosis mediates decrease in cellularity during the regression of Arthus reaction in cornea.

Authors:  N Ozaki; M Ishizaki; M Ghazizadeh; N Yamanaka
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

9.  Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury.

Authors:  Ying Wang; Yansong Li; Shawn L Dalle Lucca; Milomir Simovic; George C Tsokos; Jurandir J Dalle Lucca
Journal:  J Neuroinflammation       Date:  2010-04-09       Impact factor: 8.322

Review 10.  Properdin: New roles in pattern recognition and target clearance.

Authors:  Claudia Kemper; Dennis E Hourcade
Journal:  Mol Immunol       Date:  2008-08-08       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.